Jun 28 |
MercadoLibre, A Few Other Growth Stocks, Among New Faces In IBD 50
|
Jun 28 |
Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
|
Jun 25 |
Biotech Stock Explodes On Drug Trial News As Sales Keep Doubling
|
Jun 18 |
Mirum (MIRM) Soars on Interim Data From Liver Disease Studies
|
Jun 18 |
Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
|
Jun 17 |
Mirum stock climbs after positive interim data from liver disease drug
|
Jun 17 |
Mirum Pharmaceuticals Advances after Reporting Positive Trial Results for Prospective Cholangitis Treatment
|
Jun 17 |
Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies
|
Jun 16 |
Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024
|
Jun 7 |
Why Is Mirum Pharmaceuticals (MIRM) Down 3.4% Since Last Earnings Report?
|